Sulfafurazole
Not to be confused with sulfadiazine.
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601049 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | J01EB05 (WHO) S01AB02 (WHO) QJ01EQ05 (WHO) |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Excretion | Excreted unchanged in urine |
Identifiers | |
| |
CAS Number | 127-69-5 |
PubChem (CID) | 5344 |
DrugBank | DB00263 |
UNII | 740T4C525W |
KEGG | D00450 |
ChEMBL | CHEMBL453 |
ECHA InfoCard | 100.004.418 |
Chemical and physical data | |
Formula | C11H13N3O3S |
Molar mass | 267.30 g/mol |
3D model (Jmol) | Interactive image |
Melting point | 194 °C (381 °F) |
| |
(what is this?) (verify) |
Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment.
See also
External links
- Sulfisoxazole at the US National Library of Medicine Medical Subject Headings (MeSH)
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- DDB 30455
This article is issued from Wikipedia - version of the 11/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.